IDH1 Mutation
Oncology·MeSH: Leukemia, Myeloid, Acute
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Ivosidenib | AGIOS PHARMACEUTICALS, INC. (AGIO) |
Frequently asked questions
How many drugs are in development for IDH1 Mutation?
BioSniper tracks 1 drug in development for IDH1 Mutation across 1 company.
How many clinical trials target IDH1 Mutation?
There are 5 clinical trials targeting IDH1 Mutation tracked by BioSniper.
Deep-dive into IDH1 Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis